clinical trial · NCT03815643
Avelumab Program Rollover Study
EMD Serono Research & Development Institute, Inc.·phase3·active not recruiting·n = 205
Solid TumorsAvelumab
brief summary
The main purpose of this study is to monitor the safety and tolerability of avelumab in participants with solid tumors who continue treatment with avelumab under the same treatment regimen as in the parent avelumab study.
started
Mar 22, 2019
primary completion
Nov 24, 2026
completion
Nov 24, 2026
last updated
Sep 22, 2026
official title
An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants From Multiple Avelumab (MSB0010718C) Clinical Studies
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol